Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-06-28
2011-06-28
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S221000, C514S234200, C514S252030, C514S260100, C514S261100, C514S262100, C514S263210, C514S265100, C544S117000, C544S118000, C544S238000, C544S254000, C544S255000, C544S262000, C544S264000, C544S278000, C544S280000, C540S502000, C540S521000
Reexamination Certificate
active
07968536
ABSTRACT:
The present invention provides compounds useful as inhibitors of protein kinase. The present invention also provides compositions thereof, and methods of treating Raf-mediated diseases.
REFERENCES:
patent: 5563158 (1996-10-01), DeGrado et al.
patent: 5691329 (1997-11-01), DeGrado et al.
patent: 5760028 (1998-06-01), Jadhav et al.
patent: 5840917 (1998-11-01), Oi et al.
patent: 5872136 (1999-02-01), Anthony et al.
patent: 5877182 (1999-03-01), Nargund et al.
patent: 6017925 (2000-01-01), Duggan
patent: 6127382 (2000-10-01), Beard et al.
patent: 6214834 (2001-04-01), Jadhav et al.
patent: 6242470 (2001-06-01), Baxter et al.
patent: 6284757 (2001-09-01), Sanner
patent: 6288078 (2001-09-01), Walsh et al.
patent: 6369227 (2002-04-01), Lam et al.
patent: 6403583 (2002-06-01), Lam et al.
patent: 6500855 (2002-12-01), Lam et al.
patent: 6602871 (2003-08-01), Lam et al.
patent: 6632823 (2003-10-01), Vernier et al.
patent: 7709500 (2010-05-01), Alcaraz et al.
patent: 2003/0119811 (2003-06-01), Liverton et al.
patent: 2004/0014765 (2004-01-01), Boyle et al.
patent: 2004/0048866 (2004-03-01), Kolasa et al.
patent: 2004/0082627 (2004-04-01), Darrow et al.
patent: 2004/0097531 (2004-05-01), Ledeboer et al.
patent: 2004/0106631 (2004-06-01), Bernardelli et al.
patent: 2005/0070538 (2005-03-01), Cheng et al.
patent: 2005/0171105 (2005-08-01), Chopiuk et al.
patent: 2006/0035908 (2006-02-01), Lew et al.
patent: 2006/0183747 (2006-08-01), Freyne et al.
patent: 2006/0205721 (2006-09-01), Freyne et al.
patent: 2007/0015207 (2007-01-01), Ludovici et al.
patent: 2009/0036419 (2009-02-01), Chen et al.
patent: 10328999 (2005-01-01), None
patent: 0847992 (1998-06-01), None
patent: 1547585 (2005-06-01), None
patent: 2361474 (2001-10-01), None
patent: 11209366 (1999-08-01), None
patent: 2004161716 (2004-06-01), None
patent: 2004339159 (2004-12-01), None
patent: WO-9723480 (1997-07-01), None
patent: WO-9736901 (1997-10-01), None
patent: WO-9842323 (1998-10-01), None
patent: WO-0053602 (2000-09-01), None
patent: WO-0058300 (2000-10-01), None
patent: WO-0138309 (2001-05-01), None
patent: WO-0198294 (2001-12-01), None
patent: WO-02080928 (2002-10-01), None
patent: WO-03055491 (2003-07-01), None
patent: WO-2005066156 (2005-07-01), None
patent: WO-2005072733 (2005-08-01), None
patent: WO-2006045010 (2006-04-01), None
patent: WO-2006065703 (2006-06-01), None
patent: WO-2006074057 (2006-07-01), None
patent: WO-2006120573 (2006-11-01), None
patent: WO-2010078408 (2010-07-01), None
Smith et al., “Recent Advances in the Research and Development of RAF Kinase Inhibitors,” Current Topics in Medicinal Chemistry 6(11):1071-1089 (2006).
International Search Report for PCT/US2008/068789, mailed on Jun. 23, 2009.
Marchal et al., Bull. Soc. Chim. Belg. 69:177-193 (1960).
Plouvier et al., “Synthesis of two new thiazole-containing oligopeptides as potential DNA minor groove binding analogs of netropsin,” Heterocycles 32:693-701 (1991).
Frimurer et al., “A physicogenetic method to assign ligand-binding relationships between 7TM receptors,” Bioorg. Med. Chem. 13:3707-3712 (2005).
Cossrow Jennifer
Guan Bing
Ishchenko Alexey
Jones John Howard
Kumaravel Gnanasambandam
Choate Hall & Stewart LLP
Huck Emilie Porter
Kifle Bruck
Millennium Pharmaceuticals Inc.
Robidoux Andrea L. C.
LandOfFree
Heterocyclic compounds useful as RAF kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic compounds useful as RAF kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds useful as RAF kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2738560